News

VC-backed TransMedics debuts IPO

Andover, Massachusetts-based TransMedics, a medical technology company, has raised over $91 million for its IPO after pricing its nearly 5.7 million shares at $16 per share. The stock began trading May 2, 2019 on the NASDAQ under the ticker symbol "TMDX." Morgan Stanley and J.P. Morgan are the lead underwriters. The company's pre-IPO backers include Flagship Pioneering and Kleiner Perkins.

CirrusMD locks in $15 mln Series B

Denver-based CirrusMD, a chat-first virtual care solution, has raised $15 million in Series B funding. The investors included Drive Capital and Colorado Impact Fund.

Toyota AI Ventures unveils $100 mln fund

Toyota AI Ventures, a subsidiary of Toyota Research Institute, has launched a $100 million fund focused on investing in early-stage startups in autonomous mobility and robotics. Founded in July 2017, Toyota AI Ventures has invested in 19 startups.

Medical device firm Atia Vision inks $20 mln Series D

Campbell, California-based Atia Vision, a medical device company, has secured $20 million in Series D funding. Cormorant Asset Management led the round with participation from The Capital Partnership, AMED Ventures and Shangbay Capital.

Insurtech on pace for record year with $1.5 bln in Q1

Insight Venture Partners runs fund restructuring that could total $1 bln

Venture capital emerging manager roundup: Drive, Defy, Joe Montana’s Liquid 2 Ventures and more

Andreessen Horowitz raises $2.75 bln for core fund and its first late-stage vehicle

Rosecliff to raise $175 mln for fifth fund

Rosecliff Venture Partners is seeking to raise $175 million for its fifth fund, according to an updated SEC filing. The New York City-based venture firm invests in emerging tech companies.

HealthX Ventures to raise a $75 mln venture-capital fund

HealthX Ventures has set out to raise a $75 million second venture-capital fund, according to a filing with the SEC.